Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Divestments: 2009-2019

Historic Divestments for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Dec 2019 value amounting to -$4.2 million.

  • Ironwood Pharmaceuticals' Divestments was N/A to -$4.2 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$1.2 million, marking a year-over-year change of. This contributed to the annual value of -$4.2 million for FY2019, which is 48.94% up from last year.
  • As of FY2019, Ironwood Pharmaceuticals' Divestments stood at -$4.2 million, which was up 48.94% from -$8.3 million recorded in FY2018.
  • In the past 5 years, Ironwood Pharmaceuticals' Divestments registered a high of -$1.4 million during FY2017, and its lowest value of -$8.3 million during FY2018.
  • For the 3-year period, Ironwood Pharmaceuticals' Divestments averaged around -$4.6 million, with its median value being -$4.2 million (2019).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Divestments tumbled by 487.36% in 2018 and then spiked by 48.94% in 2019.
  • Ironwood Pharmaceuticals' Divestments (Yearly) stood at -$1.4 million in 2017, then plummeted by 487.36% to -$8.3 million in 2018, then surged by 48.94% to -$4.2 million in 2019.